Ancora Advisors’s ClearPoint Neuro CLPT Stock Holding History

Ancora Advisors’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$84.4K	–	1815
2023 Q1	$84.4K	Buy	+10,000	New	+$87.6K	﹤0.01%	807
2022 Q4	–	Sell	-14,000	Closed	-$145K	–	1822
2022 Q3	$145K	Hold	14,000	–	–	﹤0.01%	812
2022 Q2	$183K	Buy	14,000 +4,000	+40%	+$40.9K	0.01%	782
2022 Q1	$104K	Buy	10,000 +5,000	+100%	+$45.5K	﹤0.01%	1008
2021 Q4	$56K	Buy	+5,000	New	+$74.9K	﹤0.01%	1212

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CWM

Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Ancora Advisors's CLPT Position: Q2 2023 in Review

Ancora Advisors sold out of ClearPoint Neuro (CLPT) in Q2 2023, closing a stake of 10,000 shares — an estimated $84.4K sold.

Ancora Advisors first reported a position in CLPT in Q4 2021 and held it in 5 quarters. The position peaked at $183K in Q2 2022. 60 funds tracked by Wall St. Rank hold CLPT as of Q2 2023.

Ancora Advisors reported no remaining ClearPoint Neuro position as of Q2 2023 after selling out during the quarter.
Ancora Advisors sold 10,000 ClearPoint Neuro shares in Q2 2023, an estimated $84.4K.
Ancora Advisors first reported a position in ClearPoint Neuro in Q4 2021 and held it in 5 quarters.
Ancora Advisors's ClearPoint Neuro position peaked at $183K in Q2 2022.
60 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2023.

Based on Ancora Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.